Teva Pharmaceutical Indus Q3 Adj. EPS $0.58, Inline, Sales $4.264B Beat $4.22B Estimate

Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.58 per share which met the analyst consensus estimate. This is a 14.71 percent decrease over earnings of $0.68 per share from the same period last

Benzinga · 11/07/2019 12:03

Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.58 per share which met the analyst consensus estimate. This is a 14.71 percent decrease over earnings of $0.68 per share from the same period last year. The company reported quarterly sales of $4.264 billion which beat the analyst consensus estimate of $4.22 billion by 1.04 percent. This is a 5.85 percent decrease over sales of $4.529 billion the same period last year.